Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/8/2025

Propranolol Dosing for Infantile Hemangioma

Standard Dosing Protocol

  • The American Academy of Pediatrics recommends starting propranolol at 1 mg/kg/day divided into 2-3 doses, then increasing after 24 hours to a maintenance dose of 2 mg/kg/day for uncomplicated cases, with a maximum of 3 mg/kg/day for non-responders 1, 2
  • The British Society for Paediatric Dermatology suggests escalating to a maintenance dose of 2 mg/kg/day divided into 2-3 doses after 24 hours 1, 2
  • The maintenance dose range is 2-3 mg/kg/day based on high-quality RCT data showing 60% complete/nearly complete resolution at 3 mg/kg/day for 6 months versus 4% with placebo 2
  • The maximum dose is 3 mg/kg/day for non-responders 1, 3

Administration Guidelines

  • The American Academy of Pediatrics recommends giving propranolol with or after feeding to reduce hypoglycemia risk 2, 4
  • The British Society for Paediatric Dermatology suggests holding doses during reduced oral intake or vomiting to prevent hypoglycemia 2, 4

Modified Dosing for High-Risk Patients

  • The American Academy of Pediatrics recommends a starting dose of 0.5 mg/kg/day for preterm infants, low birthweight, faltering growth, or conditions predisposing to hypoglycemia 1, 5
  • The British Society for Paediatric Dermatology suggests obtaining brain MRI/MRA, echocardiogram, and ECG before full-dose propranolol for patients with PHACE syndrome 1, 3

Treatment Duration

  • The American Academy of Pediatrics recommends continuing treatment until at least 12 months of age to minimize rebound growth risk 2, 4
  • The British Society for Paediatric Dermatology suggests that 6 months duration is superior to 3 months (60% vs lower response rates) 2

Pre-Treatment Assessment

  • The American Academy of Pediatrics recommends a thorough history and physical examination including auscultation, peripheral pulses, abdominal exam for hepatomegaly 5
  • The British Society for Paediatric Dermatology suggests measuring heart rate and blood pressure before starting propranolol 5

Monitoring During Treatment

  • The American Academy of Pediatrics recommends routine follow-up every 2-3 months for stable patients 1, 3
  • The British Society for Paediatric Dermatology suggests adjusting the dose for weight at clinic visits 1, 3

Critical Safety Considerations

  • The American Academy of Pediatrics recommends holding propranolol during reduced oral intake or vomiting (hypoglycemia risk) 2, 5, 4
  • The British Society for Paediatric Dermatology suggests that contraindications include heart block, decompensated heart failure, asthma/obstructive airway disease, cardiogenic shock, and sinus node dysfunction without pacemaker 4, 3, 5

Special Populations

  • The American Academy of Pediatrics recommends early treatment for vision-threatening periocular hemangiomas to prevent amblyopia, refractive errors, strabismus 1, 3
  • The British Society for Paediatric Dermatology suggests that airway hemangiomas require otolaryngology co-management 3